Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk

Lue Ping Zhao, Pavitra Roychoudhury, Peter B. Gilbert, Joshua T. Schiffer, Terry P. Lybrand, Thomas H. Payne, April K. Randhawa, Sara E Thiebaud, Margaret G. Mills, Alexander L. Greninger, Chul‐Woo Pyo, Ruihan Wang, Renyu Li, Alexander Thomas, Brandon Norris, Wyatt C. Nelson, Keith R. Jerome, Daniel E. GeraghtyScientific 2022 · DOI

Abstract

SARS-CoV-2 is spreading worldwide with continuously evolving variants, some of which occur in the Spike protein and appear to increase viral transmissibility. However, variants that cause severe COVID-19 or lead to other breakthroughs have not been well characterized. To discover such viral variants, we assembled a cohort of 683 COVID-19 patients; 388 inpatients ("cases") and 295 outpatients ("controls") from April to August 2020 using electronically captured COVID test request forms and sequenced their viral genomes. To improve the analytical power, we accessed 7137 viral sequences in Washington State to filter out viral single nucleotide variants (SNVs) that did not have significant expansions over the collection period. Applying this filter led to the identification of 53 SNVs that were statistically significant, of which 13 SNVs each had 3 or more variant copies in the discovery cohort. Correlating these selected SNVs with case/control status, eight SNVs were found to significantly associate with inpatient status (q-values < 0.01). Using temporal synchrony, we identified a four SNV-haplotype (t19839-g28881-g28882-g28883) that was significantly associated with case/control status (Fisher's exact p = 2.84 × 10<sup>-11</sup>). This haplotype appeared in April 2020, peaked in June, and persisted into January 2021. The association was replicated (OR = 5.46, p-value = 4.71 × 10<sup>-12</sup>) in an independent cohort of 964 COVID-19 patients (June 1, 2020 to March 31, 2021). The haplotype included a synonymous change N73N in endoRNase, and three non-synonymous changes coding residues R203K, R203S and G204R in the nucleocapsid protein. This discovery points to the potential functional role of the nucleocapsid protein in triggering "cytokine storms" and severe COVID-19 that led to hospitalization. The study further emphasizes a need for tracking and analyzing viral sequences in correlations with clinical status.

Introduction

Throughout the pandemic, genomic surveillance has primarily focused on the Spike protein, as mutations there often lead to higher transmissibility or vaccine escape. However, the genetic drivers of virulence—the virus's ability to cause severe disease—remain poorly understood. A major challenge is the "siloing" of data: genomic databases often lack detailed clinical outcomes, while clinical databases rarely include full viral sequences. This study bridges that gap by correlating specific viral Single Nucleotide Variants (SNVs) with the clinical status (inpatient vs. outpatient) of patients in Washington State.

Methods and Data

The researchers employed a two-stage "discovery and replication" study design. First, they filtered for "successful" mutations by analyzing 7,137 viral sequences from Washington State (GISAID) to identify SNVs actively expanding in the population. This narrowed thousands of possibilities down to 53 significant SNVs.

The discovery cohort consisted of 683 patients (388 inpatients and 295 outpatients) whose viral genomes were sequenced. Logistic regression was used to find SNVs associated with hospitalization. Findings were then validated in an independent replication cohort of 964 patients. To account for pandemic "waves," Generalized Additive Models (GAMs) were used to treat time as a non-linear variable, ensuring that mutations appearing during hospitalization peaks weren't misidentified as high-risk due to timing alone.

Key Results

The analysis identified several SNVs with significant associations with hospitalization status. Specifically, eight SNVs showed q-values below 0.01, indicating a strong statistical link to inpatient status.

Significance and prevalence of viral SNVs associated with hospitalization risk. Red dots indicate variants with q-values < 0.01 and proportions > 0.10.

The most striking result was a four-SNV haplotype (t19839-g28881-g28882-g28883) that travels together. In the replication cohort, this haplotype was associated with a 5.46-fold increased risk of hospitalization ($p = 4.71 \times 10^{-12}$) after adjusting for age, sex, and collection time. Interestingly, the D614G mutation in the Spike protein showed no association with hospitalization risk, suggesting that transmissibility and virulence are genetically distinct traits.

Discussion: The Role of the Nucleocapsid Protein

The significant mutations were located in the Nucleocapsid (N) protein and endoRNase (nsp15), rather than the Spike protein. The N protein is essential for viral RNA packaging and interfering with host immune responses. The identified mutations (R203K, R203S, G204R) occur in a "flexible linker" region, potentially altering protein flexibility and accelerating viral replication or triggering "cytokine storms."

Temporal distribution of variant haplotypes in Washington State from January 2020 to February 2021.

The high-risk SNVs showed synchronized expansion patterns, appearing in April 2020 and peaking in June. Even synonymous mutations, like N73N in endoRNase, may impact the virus by altering RNA stability or translation kinetics, potentially providing a competitive advantage.

Limitations and Future Directions

While the statistical association is robust, hospitalization is an imperfect proxy for severity, as some patients are hospitalized for non-COVID reasons. Furthermore, the data was collected pre-vaccination; future research must determine if these mutations carry similar risks in vaccinated populations. Finally, "wet lab" experiments are necessary to definitively prove the biological mechanisms by which these N-protein mutations influence disease severity.

Summary updated

Abstract

SARS-CoV-2 is spreading worldwide with continuously evolving variants, some of which occur in the Spike protein and appear to increase viral transmissibility. However, variants that cause severe COVID-19 or lead to other breakthroughs have not been well characterized. To discover such viral variants, we assembled a cohort of 683 COVID-19 patients; 388 inpatients ("cases") and 295 outpatients ("controls") from April to August 2020 using electronically captured COVID test request forms and sequenced their viral genomes. To improve the analytical power, we accessed 7137 viral sequences in Washington State to filter out viral single nucleotide variants (SNVs) that did not have significant expansions over the collection period. Applying this filter led to the identification of 53 SNVs that were statistically significant, of which 13 SNVs each had 3 or more variant copies in the discovery cohort. Correlating these selected SNVs with case/control status, eight SNVs were found to significantly associate with inpatient status (q-values < 0.01). Using temporal synchrony, we identified a four SNV-haplotype (t19839-g28881-g28882-g28883) that was significantly associated with case/control status (Fisher's exact p = 2.84 × 10<sup>-11</sup>). This haplotype appeared in April 2020, peaked in June, and persisted into January 2021. The association was replicated (OR = 5.46, p-value = 4.71 × 10<sup>-12</sup>) in an independent cohort of 964 COVID-19 patients (June 1, 2020 to March 31, 2021). The haplotype included a synonymous change N73N in endoRNase, and three non-synonymous changes coding residues R203K, R203S and G204R in the nucleocapsid protein. This discovery points to the potential functional role of the nucleocapsid protein in triggering "cytokine storms" and severe COVID-19 that led to hospitalization. The study further emphasizes a need for tracking and analyzing viral sequences in correlations with clinical status.
BibTeX
@inproceedings{zhao2022mutations,
  author = {Lue Ping Zhao and Pavitra Roychoudhury and Peter B. Gilbert and Joshua T. Schiffer and Terry P. Lybrand and Thomas H. Payne and April K. Randhawa and Sara E Thiebaud and Margaret G. Mills and Alexander L. Greninger and Chul‐Woo Pyo and Ruihan Wang and Renyu Li and Alexander Thomas and Brandon Norris and Wyatt C. Nelson and Keith R. Jerome and Daniel E. Geraghty},
  title = {{Mutations in viral nucleocapsid protein and endoRNase are discovered to associate with COVID19 hospitalization risk}},
  booktitle = {Scientific},
  year = {2022},
  doi = {10.1038/s41598-021-04376-4},
}
Figure